Metabolic disorders in patients with chronic kidney failure
- PMID: 17298212
- DOI: 10.33549/physiolres.931128
Metabolic disorders in patients with chronic kidney failure
Abstract
This review article summarizes the problems of metabolic disorders and nutrition imbalances that often occur in chronic kidney failure (CKF) or following regular dialysis treatment. In this survey, we cover the pathogenesis of these disorders, their clinical consequences, and their association with the most severe complications of chronic kidney failure and dialysis treatment. These complications are primarily atherosclerosis, malnutrition, anemia, hyperparathyroidism, and other serious problems that markedly and negatively affect prognosis and the quality of life of uremic patients. Risk factors for cardiovascular disease are discussed in-depth because cardiovascular disease is the leading cause of death in patients with chronic kidney failure. It is important to pay attention to the development of these complications because early diagnosis and therapy can improve the prognosis for these patients and reduce treatment costs.
Similar articles
-
Disorders of protein and lipid metabolism associated with chronic renal failure and chronic dialysis.Ann Clin Lab Sci. 1981 Jul-Aug;11(4):350-60. Ann Clin Lab Sci. 1981. PMID: 7023349 Review.
-
Disorders of carbohydrate and lipid metabolism in uremia.Nephron. 1975;14(2):153-62. doi: 10.1159/000180445. Nephron. 1975. PMID: 1093054 Review.
-
[Disorders of protein and amino acids metabolism in chronic dialysis patients].Nihon Rinsho. 1992 Jan;50 Suppl:535-43. Nihon Rinsho. 1992. PMID: 1578735 Japanese. No abstract available.
-
[Protein and amino acid metabolism disorders in hemodialysis patients].Nihon Rinsho. 2004 Jun;62 Suppl 6:124-35. Nihon Rinsho. 2004. PMID: 15250281 Review. Japanese. No abstract available.
-
Cardiovascular disease in patients with chronic kidney disease. A clinical review.Minerva Urol Nefrol. 2007 Sep;59(3):281-97. Minerva Urol Nefrol. 2007. PMID: 17912225 Review.
Cited by
-
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients.BMC Med Genomics. 2013 May 10;6:17. doi: 10.1186/1755-8794-6-17. BMC Med Genomics. 2013. PMID: 23663527 Free PMC article.
-
Mechanism of insulin resistance in a rat model of kidney disease and the risk of developing type 2 diabetes.PLoS One. 2017 May 1;12(5):e0176650. doi: 10.1371/journal.pone.0176650. eCollection 2017. PLoS One. 2017. PMID: 28459862 Free PMC article.
-
Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder.Front Med. 2017 Sep;11(3):378-385. doi: 10.1007/s11684-017-0541-8. Epub 2017 Jun 14. Front Med. 2017. PMID: 28623542
-
Analysis of Arterial Blood Gas Report in Chronic Kidney Diseases - Comparison between Bedside and Multistep Systematic Method.J Clin Diagn Res. 2016 Aug;10(8):BC01-5. doi: 10.7860/JCDR/2016/19830.8252. Epub 2016 Aug 1. J Clin Diagn Res. 2016. PMID: 27656429 Free PMC article.
-
Peroxisome proliferator-activated receptor-γ-coactivator 1α (PGC-1α) gene expression in chronic kidney disease patients on hemodialysis: relation to hemodialysis-related cardiovascular morbidity and mortality.Int Urol Nephrol. 2017 Oct;49(10):1835-1844. doi: 10.1007/s11255-017-1628-5. Epub 2017 May 26. Int Urol Nephrol. 2017. PMID: 28550474
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
